JP2018080173A5 - - Google Patents

Download PDF

Info

Publication number
JP2018080173A5
JP2018080173A5 JP2017237159A JP2017237159A JP2018080173A5 JP 2018080173 A5 JP2018080173 A5 JP 2018080173A5 JP 2017237159 A JP2017237159 A JP 2017237159A JP 2017237159 A JP2017237159 A JP 2017237159A JP 2018080173 A5 JP2018080173 A5 JP 2018080173A5
Authority
JP
Japan
Prior art keywords
carbonyl
phenyl
amino
cyano
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017237159A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018080173A (ja
JP6760249B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2018080173A publication Critical patent/JP2018080173A/ja
Publication of JP2018080173A5 publication Critical patent/JP2018080173A5/ja
Application granted granted Critical
Publication of JP6760249B2 publication Critical patent/JP6760249B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017237159A 2015-01-09 2017-12-11 三環性スピロ化合物 Active JP6760249B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015002712 2015-01-09
JP2015002712 2015-01-09

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2016568753A Division JP6269862B2 (ja) 2015-01-09 2016-01-08 三環性スピロ化合物

Publications (3)

Publication Number Publication Date
JP2018080173A JP2018080173A (ja) 2018-05-24
JP2018080173A5 true JP2018080173A5 (https=) 2019-02-14
JP6760249B2 JP6760249B2 (ja) 2020-09-23

Family

ID=56356032

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016568753A Active JP6269862B2 (ja) 2015-01-09 2016-01-08 三環性スピロ化合物
JP2017237159A Active JP6760249B2 (ja) 2015-01-09 2017-12-11 三環性スピロ化合物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2016568753A Active JP6269862B2 (ja) 2015-01-09 2016-01-08 三環性スピロ化合物

Country Status (22)

Country Link
US (4) US10077247B2 (https=)
EP (2) EP3778562A1 (https=)
JP (2) JP6269862B2 (https=)
KR (2) KR102376248B1 (https=)
CN (2) CN111039916B (https=)
AU (1) AU2016205680B2 (https=)
BR (1) BR112017014740B1 (https=)
DK (1) DK3243813T3 (https=)
ES (1) ES2839203T3 (https=)
HU (1) HUE052969T2 (https=)
IL (1) IL253361B (https=)
MX (2) MX389142B (https=)
MY (1) MY196172A (https=)
NZ (1) NZ733575A (https=)
PH (1) PH12017501255B1 (https=)
PL (1) PL3243813T3 (https=)
PT (1) PT3243813T (https=)
RU (1) RU2707073C2 (https=)
SG (2) SG10201912589XA (https=)
TW (8) TWI832784B (https=)
WO (1) WO2016111347A1 (https=)
ZA (1) ZA201704591B (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ733575A (en) * 2015-01-09 2022-10-28 Ono Pharmaceutical Co Tricyclic spiro compound
CR20180323A (es) 2015-11-20 2018-08-06 Idorsia Pharmaceuticals Ltd Derivados de indol n-sustituídos como moduladores de los receptores de pge2
HUE057799T2 (hu) 2016-07-07 2022-06-28 Ono Pharmaceutical Co EP4 antagonistát és immunellenõrzõpont gátlót tartalmazó kombináció
CN110621667A (zh) 2017-05-18 2019-12-27 爱杜西亚药品有限公司 嘧啶衍生物
PL3625228T3 (pl) 2017-05-18 2021-12-20 Idorsia Pharmaceuticals Ltd Pochodne pirymidyny jako modulatory receptora pge2
EA201992676A1 (ru) 2017-05-18 2020-05-06 Идорсия Фармасьютиклз Лтд Фенильные производные в качестве модуляторов pge2 рецепторов
CN110621671A (zh) 2017-05-18 2019-12-27 爱杜西亚药品有限公司 作为pge2受体调节剂的苯并呋喃及苯并噻吩衍生物
EP3625224B1 (en) 2017-05-18 2021-08-04 Idorsia Pharmaceuticals Ltd N-substituted indole derivatives
WO2018216640A1 (ja) 2017-05-22 2018-11-29 小野薬品工業株式会社 Ep4アンタゴニスト
JP7159007B2 (ja) * 2017-11-01 2022-10-24 小野薬品工業株式会社 脳腫瘍の治療のための医薬
CN112300019A (zh) * 2019-07-31 2021-02-02 华东师范大学 一种邻乙酰氨基苯丁酸类化合物的制备方法
US20230390303A1 (en) 2020-11-13 2023-12-07 Ono Pharmaceutical Co., Ltd. Cancer treatment by combination of ep4 antagonist and immune checkpoint inhibitor
JP2024016314A (ja) * 2020-12-24 2024-02-07 小野薬品工業株式会社 一般式(i-a)で示される化合物、その薬学的に許容される塩、またはそれらの水和物と免疫チェックポイント阻害薬および/またはep4受容体拮抗薬との組み合わせ
CN117377656A (zh) * 2021-05-28 2024-01-09 南京明德新药研发有限公司 苯并螺杂环衍生物及其应用
US20250092008A1 (en) 2021-08-10 2025-03-20 Ono Pharmaceutical Co., Ltd. Process for making an ep4 antagonist
WO2025135108A1 (ja) * 2023-12-22 2025-06-26 Agc株式会社 新規なep4アンタゴニスト
WO2025212569A1 (en) 2024-04-05 2025-10-09 Park City Bio, LLC Selective serotonin receptor modultors and methods of making and using the same

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2081679A1 (en) 1991-11-27 1993-05-28 Raj N. Misra Gem-dialkyl-7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
EP1071648A2 (en) * 1998-03-13 2001-01-31 Merck Frosst Canada & Co. Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
AU756333B2 (en) 1998-03-13 2003-01-09 Merck Frosst Canada & Co. Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
US6242493B1 (en) * 1998-03-13 2001-06-05 Merck Frosst Canada & Co. Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
US6211197B1 (en) * 1998-10-07 2001-04-03 Merck Frosst Canada & Co. Prostaglandin receptor ligands
CA2420042A1 (en) * 2000-08-22 2003-02-18 Mikio Ogawa Carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical agents comprising the same as active ingredient
GB0031302D0 (en) * 2000-12-21 2001-01-31 Glaxo Group Ltd Napthalene derivatives
MXPA04001253A (es) * 2001-08-09 2004-06-03 Ono Pharmaceutical Co Derivados de acidos carboxilicos y agente farmaceutico que comprende los mismos como ingrediente activo.
AU2003211574A1 (en) 2002-03-05 2003-09-16 Ono Pharmaceutical Co., Ltd. 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
US7205328B2 (en) * 2002-10-21 2007-04-17 Irm Llc Oxindoles with anti-HIV activity
UA80474C2 (en) * 2003-02-26 2007-09-25 Sugen Inc Aminoheteroaryl compounds as inhibitors of protein kinase
AP2006003769A0 (en) 2004-05-04 2006-10-31 Pfizer Ortho substituted aryl or heteroaryl amide compounds
GB0808282D0 (en) 2008-05-07 2008-06-11 Medical Res Council Compounds for use in stabilizing p53 mutants
WO2012071458A1 (en) * 2010-11-22 2012-05-31 Array Biopharma Inc. Heterocyclic inhibitors of beta - secretase for the treatment of neurodegenerative diseases
EP2729445B1 (en) * 2011-07-04 2015-10-21 Rottapharm Biotech S.r.l. Cyclic amine derivatives as ep4 receptor antagonists
US20150004175A1 (en) 2011-12-13 2015-01-01 Yale University Compositions and Methods for Reducing CTL Exhaustion
RU2016101548A (ru) * 2013-07-03 2017-08-08 Ф. Хоффманн-Ля Рош Аг Соединения амидов гетероарилпиридона и азапиридона
NZ733575A (en) * 2015-01-09 2022-10-28 Ono Pharmaceutical Co Tricyclic spiro compound
HUE057799T2 (hu) * 2016-07-07 2022-06-28 Ono Pharmaceutical Co EP4 antagonistát és immunellenõrzõpont gátlót tartalmazó kombináció

Similar Documents

Publication Publication Date Title
JP2018080173A5 (https=)
JP2017505762A5 (https=)
ES2580481T3 (es) Derivados de aminoquinazolina y sus sales, y métodos de uso
SI3022192T1 (en) Piperidinyl indole derivatives and their use as inhibitors of complementary factor B
RU2017124136A (ru) Трициклическое спиро-соединение
JP2018515525A5 (https=)
JP2019509978A5 (https=)
JP2009543867A5 (https=)
JP2011502958A5 (https=)
JP2010514689A5 (https=)
JP2012532931A5 (https=)
RU2018121499A (ru) Гипоксантины в качестве ингибиторов убиквитин-специфической протеазы 1
JP2017502940A5 (https=)
JP2016505042A5 (https=)
JP2011521911A5 (https=)
IL298983B1 (en) Macrocyclines with P2' heterocyclic groups as factor XIA inhibitors
JP2017533958A5 (https=)
JP2017515844A5 (https=)
IL258577A (en) 2,4-dihydroxy-nicotinamides as apj agonists
JP2013500997A5 (https=)
JP2004175807A5 (https=)
JP2012528166A5 (https=)
JPWO2020017587A5 (https=)
SI2961736T1 (en) Histone demethylase inhibitors
JP2013529611A5 (https=)